Stockreport

LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) [Yahoo! Finance]

JAPAN TOBACCO UNSP/ADR  (JAPAY) 
NASDAQ:AMEX Investor Relations: gungho.co.jp/en/ir
PDF cream vehicle and was generally well tolerated in adolescents, aged 12-17, with moderate to severe Chronic Hand Eczema (CHE) for whom topical corticosteroids are inadequ [Read more]